{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:14:39Z","timestamp":1770884079781,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00210-025-04470-8","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T08:44:17Z","timestamp":1757493857000},"page":"2711-2741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["In silico design, synthesis of a novel chalcone derivative and its in vitro and in vivo anticancer activity against colon cancer-induced mouse model"],"prefix":"10.1007","volume":"399","author":[{"given":"Uday Raj","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushavan","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurubasavaraja Swamy","family":"Purawargaar Matada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjunatha","family":"P M","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Janadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra","family":"Vada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Haribabu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nageena","family":"Taj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayathri","family":"S V","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susovan","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Chanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"issue":"4","key":"4470_CR1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/10496475.2023.2225147","volume":"29","author":"CJ Anjali","year":"2023","unstructured":"Anjali CJ, Pareeth CM, Babu TD (2023) Analysis of cytotoxic and antitumor potential of Passiflora quadrangularis. J Herbs Spices Med Plants 29(4):452\u2013469. https:\/\/doi.org\/10.1080\/10496475.2023.2225147","journal-title":"J Herbs Spices Med Plants"},{"key":"4470_CR2","unstructured":"Chandrashekar NS, Prasanth VV (2008) Clinical evaluation of 5-fluorouracil from transdermal patches on EAC and DLA cell-induced tumors in mice. Asian Pac J Cancer Prev APJCP 9:437\u201340"},{"key":"4470_CR3","doi-asserted-by":"publisher","first-page":"153303382311784","DOI":"10.1177\/15330338231178403","volume":"22","author":"A Dey","year":"2023","unstructured":"Dey A, Mitra A, Pathak S, Prasad S, Zhang AS, Zhang H, Sun X-F, Banerjee A (2023) Recent advancements, limitations, and future perspectives of the use of personalized medicine in treatment of colon cancer. Technol Cancer Res Treat 22:153303382311784","journal-title":"Technol Cancer Res Treat"},{"key":"4470_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM14020216","author":"MA El-Atawy","year":"2024","unstructured":"El-Atawy MA, Hanna DH, Bashal AH, Ahmed HA, Alshammari EM, Hamed EA, Aljohani AR, Omar AZ (2024) Synthesis, characterization, antioxidant, and anticancer activity against colon cancer cells of some cinnamaldehyde-based chalcone derivatives. Biomolecules. https:\/\/doi.org\/10.3390\/BIOM14020216","journal-title":"Biomolecules"},{"key":"4470_CR5","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1007\/s11164-017-2977-5","volume":"43","author":"SL Gaonkar","year":"2017","unstructured":"Gaonkar SL, Vignesh UN (2017) Synthesis and pharmacological properties of chalcones: a review. Res Chem Intermed 43:6043\u20136077","journal-title":"Res Chem Intermed"},{"issue":"1","key":"4470_CR6","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1038\/s41598-024-53514-1","volume":"14","author":"D Gheidari","year":"2024","unstructured":"Gheidari D, Mehrdad M, Bayat M (2024) Synthesis, docking, MD simulation, ADMET, drug likeness, and DFT studies of novel furo [2, 3-b] indol-3a-ol as promising cyclin-dependent kinase 2 inhibitors. Sci Rep 14(1):3084. https:\/\/doi.org\/10.1038\/s41598-024-53514-1","journal-title":"Sci Rep"},{"issue":"1","key":"4470_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/antiox12010134","volume":"12","author":"AR Ghosh","year":"2023","unstructured":"Ghosh AR, Alsayari A, Habib AH, Wahab S, Nadig APR, Rafeeq MM, Binothman N, Aljadani M, Al-Dhuayan IS, Alaqeel NK et al (2023) Anti-tumor potential of Gymnema sylvestre saponin rich fraction on in vitro breast cancer cell lines and in vivo tumor-bearing mouse models. Antioxidants 12(1):134. https:\/\/doi.org\/10.3390\/antiox12010134","journal-title":"Antioxidants"},{"issue":"88","key":"4470_CR8","first-page":"10.1016\/j.bioor","volume":"102913","author":"GP Jeyapal","year":"2019","unstructured":"Jeyapal GP, Krishnasamy R, Suzuki CK, Venkatesh S, Chandrasekar MJ (2019) In-silico design and synthesis of N9-substituted \u03b2-Carbolines as PLK-1 inhibitors and their in-vitro\/in-vivo tumor suppressing evaluation. Bioorg Chem 102913(88):10.1016\/j.bioorg.2019.04.007","journal-title":"Bioorg Chem"},{"key":"4470_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10555-012-9404-6","volume":"32","author":"RL Johnson","year":"2013","unstructured":"Johnson RL, Fleet JC (2013) Animal models of colorectal cancer. Cancer Metastasis Rev 32:39\u201361","journal-title":"Cancer Metastasis Rev"},{"key":"4470_CR10","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1007\/s13738-022-02610-y","volume":"19","author":"AJ Joshi","year":"2022","unstructured":"Joshi AJ, Bhojwani HR, Joshi UJ et al (2022) Cinnamamide-chalcone derivatives as CDK2 inhibitors: synthesis, pharmacological evaluation, and molecular modelling study. J Iran Chem Soc 19:4445\u20134455. https:\/\/doi.org\/10.1007\/s13738-022-02610-y","journal-title":"J Iran Chem Soc"},{"key":"4470_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.phrs.2017.11.022","volume":"129","author":"E Karimi-Sales","year":"2018","unstructured":"Karimi-Sales E, Mohaddes G, Alipour MR (2018) Chalcones as putative hepatoprotective agents: preclinical evidence and molecular mechanisms. Pharmacol Res 129:177\u2013187. https:\/\/doi.org\/10.1016\/j.phrs.2017.11.022","journal-title":"Pharmacol Res"},{"issue":"4","key":"4470_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/1574885514666191211122437","volume":"15","author":"M Khatun","year":"2020","unstructured":"Khatun M, Islam F, Gopalan V, Rahman MM, Zuberi N, Khatun L, Rakib MA, Islam MA, Lam AK, Khanam JA (2020) 2\u2019, 4\u2019-dihydroxy-3, 4-methylenedioxychalcone activate mitochondrial apoptosis of Ehrlich ascites carcinoma cells. Current Drug Therapy 15(4):337\u2013350. https:\/\/doi.org\/10.2174\/1574885514666191211122437","journal-title":"Current Drug Therapy"},{"key":"4470_CR13","doi-asserted-by":"publisher","unstructured":"Kumar RS, Rajkapoor B, Perumal P (2011) In vitro and in vivo anticancer activity of Indigofera cassioides Rottl. Ex. DC. Asian Pac J Trop 4(5):379\u201385. https:\/\/doi.org\/10.1016\/S1995-7645(11)60108-9","DOI":"10.1016\/S1995-7645(11)60108-9"},{"issue":"10","key":"4470_CR14","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.3390\/molecules28104009","volume":"28","author":"FF Leite","year":"2023","unstructured":"Leite FF, de Sousa NF, de Oliveira BHM, Duarte GD, Ferreira MDL, Scotti MT, Filho JMB, Rodrigues LC, de Moura RO, Mendon\u00e7a-Junior FJB et al (2023) Anticancer activity of chalcones and its derivatives: review and in silico studies. Molecules 28(10):4009. https:\/\/doi.org\/10.3390\/molecules28104009","journal-title":"Molecules"},{"key":"4470_CR15","first-page":"448","volume":"16","author":"AN Pande","year":"2017","unstructured":"Pande AN, Biswas S, Reddy ND, Jayashree BS, Kumar N, Rao CM (2017) In vitro and in vivo anticancer studies of 2\u2019-hydroxy chalcone derivatives exhibit apoptosis in colon cancer cells by HDAC inhibition and cell cycle arrest. Excli J 16:448\u2013463","journal-title":"Excli J"},{"key":"4470_CR16","doi-asserted-by":"crossref","unstructured":"Qian H, Liu D, Lv C (2011) Synthesis of chalcones via Claisen-Schmidt reaction catalyzed by sulfonic acid-functional ionic liquids. Ind Eng Chem Res 50(2):1146\u20131149","DOI":"10.1021\/ie101790k"},{"key":"4470_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.592654","author":"B Salehi","year":"2021","unstructured":"Salehi B, Quispe C, Chamkhi I et al (2021) Pharmacological properties of chalcones: a review of preclinical including molecular mechanisms and clinical evidence. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2020.592654","journal-title":"Front Pharmacol"},{"key":"4470_CR18","unstructured":"Shah R, Karki S, Shah N, Dhakal S, Singh SK, Chaudhari RK (2019) Histopathological study of prostatic diseases in bpkihs, nepal: a hospital based study. Int J Health Sci 9(2):77\u201383"},{"issue":"7","key":"4470_CR19","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.3390\/ijms26073186","volume":"26","author":"V Sudarshan","year":"2025","unstructured":"Sudarshan V, Shyamjith P, Kumar S, Ravindran F, Choudhary B, Karki SS (2025) Investigation of anti-cancer properties of novel curcuminoids in leukemic cells and Dalton lymphoma ascites model. Int J Mol Sci 26(7):3186. https:\/\/doi.org\/10.3390\/ijms26073186","journal-title":"Int J Mol Sci"},{"issue":"292","key":"4470_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cbi.2018.07.005","volume":"25","author":"P Takac","year":"2018","unstructured":"Takac P, Kello M, Pilatova MB, Kudlickova Z, Vilkova M, Slepcikova P, Petik P, Mojzis J (2018) New chalcone derivative exhibits antiproliferative potential by inducing G2\/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. Chem Biolog Interact 25(292):37\u201349. https:\/\/doi.org\/10.1016\/j.cbi.2018.07.005","journal-title":"Chem Biolog Interact"},{"key":"4470_CR21","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1186\/s12885-015-1901-x","volume":"15","author":"S Xu","year":"2015","unstructured":"Xu S, Chen M, Chen W et al (2015) Chemopreventive effect of chalcone derivative, L2H17, in colon cancer development. BMC Cancer 15:870. https:\/\/doi.org\/10.1186\/s12885-015-1901-x","journal-title":"BMC Cancer"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04470-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04470-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:48:19Z","timestamp":1770882499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04470-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4470"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04470-8","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments were approved by the\u00a0Institutional Animal Ethics Committee (IAEC)\u00a0of Acharya and BM Reddy College of Pharmacy. The study adhered to the guidelines of the\u00a0Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India.Approval Number:\u00a0[IAEC\/ABMRCP\/2023\u20132024\/24].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}